RE: Ge Healthcare boss talking about AI imagery16 Jan 2025 14:24
Tyke,
Interesting
In February 2023, we obtained our first Orphan Drug Designation (ODD) for our candidate drug IB003 in the treatment of glioblastoma (GBM) which applies to both adult and paediatric populations.
• We applied for FDA Fast Track Designation for IB003 and this was granted in December 2023.